UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006580
Receipt number R000007792
Scientific Title Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical care
Date of disclosure of the study information 2011/10/24
Last modified on 2011/10/20 15:42:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical care

Acronym

Efficacy of rt-thrombomodulin for DIC in critical care

Scientific Title

Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical care

Scientific Title:Acronym

Efficacy of rt-thrombomodulin for DIC in critical care

Region

Japan


Condition

Condition

disseminated intravascular coagulation

Classification by specialty

Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the efficacy and safety of recombinant thrombomodulin for DIC. To clarify a correlation between the efficacy of thrombomodulin and levels of HMGB1

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Laboratory data of DIC

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

administration of recombinant thrombomodulin

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients diagnosed as DIC

Key exclusion criteria

active bleeding

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keiji Kumon

Organization

Nara Hospital, Kinki University School of Medicine

Division name

Critical Care Medicine

Zip code


Address

1248-1, Otoda, Ikoma, Nara

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Keiji Kumon

Organization

Nara Hospital, Kinki University School of Medicine

Division name

Critical Care Medicine

Zip code


Address


TEL

0743-77-0880

Homepage URL


Email

kumon@nara.med.kindai.ac.jp


Sponsor or person

Institute

Critical Care Medicine, Nara Hospital, Kinki University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Asahi-Kasei Pharma

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 10 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2011 Year 10 Month 13 Day

Date of IRB


Anticipated trial start date

2011 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 10 Month 20 Day

Last modified on

2011 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007792


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name